lost weight on semaglutide but not tirzepatide 7 Reasons You Aren't Losing Weight Loss Drugs Semaglutide vs. Tirzepatide for Weight

After careful reading of the remaining articles, 29 studies were removed, because the exposure/event of interest was not reported

Mounjaro 15 mg gave an average weight loss of 22.5% in SURMOUNT-1, and Wegovy 7.2 mg gave 20.7% in STEP UP, a difference of around 1 to 2 percentage points

These drugs are administered through subcutaneous injection once a week and mimic the hormones that your body naturally makes that keep your metabolism running properly

In addition to weight loss, semaglutide may be used to help manage diabetes and reduce cardiovascular risk factors associated with obesity

Recent research suggests that GIP may actually help stabilize some of the side effects caused by GLP-1

The Cardiovascular Effect of Tirzepatide: A Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide Dual Agonist 1 , 2 Yoo La Lee, 3 and Chang Hee Jung 1 , 2 Abstract Glucagon-like peptide-1 (GLP-1) receptor agonists have been used extensively in the clinic and have an established safety profile in cardiovascular disease settings